254 related articles for article (PubMed ID: 37800288)
61. Prebiotics and Postbiotics Synergistic Delivery Microcapsules from Microfluidics for Treating Colitis.
Yang K; Wang X; Huang R; Wang H; Lan P; Zhao Y
Adv Sci (Weinh); 2022 May; 9(16):e2104089. PubMed ID: 35403829
[TBL] [Abstract][Full Text] [Related]
62. Gut microbiome as a treatment in colorectal cancer.
Khan M; Shah S; Shah W; Khan I; Ali H; Ali I; Ullah R; Wang X; Mehmood A; Wang Y
Int Rev Immunol; 2024; 43(4):229-247. PubMed ID: 38343353
[TBL] [Abstract][Full Text] [Related]
63. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
Wei Y; Peng S; Lian C; Kang Q; Chen J
Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
[TBL] [Abstract][Full Text] [Related]
64. Gut Microbiota in Cancer Immune Response and Immunotherapy.
Zhou CB; Zhou YL; Fang JY
Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
[TBL] [Abstract][Full Text] [Related]
65. Antibiotic Resistance and Microbiota Response.
Santacroce L; Di Domenico M; Montagnani M; Jirillo E
Curr Pharm Des; 2023; 29(5):356-364. PubMed ID: 36537602
[TBL] [Abstract][Full Text] [Related]
66. Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy.
Kvakova M; Kamlarova A; Stofilova J; Benetinova V; Bertkova I
World J Gastroenterol; 2022 Jul; 28(27):3370-3382. PubMed ID: 36158273
[TBL] [Abstract][Full Text] [Related]
67. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis.
Zhang XF; Guan XX; Tang YJ; Sun JF; Wang XK; Wang WD; Fan JM
Eur J Nutr; 2021 Aug; 60(5):2855-2875. PubMed ID: 33555375
[TBL] [Abstract][Full Text] [Related]
68. Gut Microbiota in Psoriasis.
Buhaș MC; Gavrilaș LI; Candrea R; Cătinean A; Mocan A; Miere D; Tătaru A
Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889927
[TBL] [Abstract][Full Text] [Related]
69. Role of Microbiome and Antibiotics in Autoimmune Diseases.
Vangoitsenhoven R; Cresci GAM
Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
[TBL] [Abstract][Full Text] [Related]
70. Prebiotics-Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer.
Zheng DW; Li RQ; An JX; Xie TQ; Han ZY; Xu R; Fang Y; Zhang XZ
Adv Mater; 2020 Nov; 32(45):e2004529. PubMed ID: 33006175
[TBL] [Abstract][Full Text] [Related]
71. Potential Impacts of Prebiotics and Probiotics on Cancer Prevention.
Samanta S
Anticancer Agents Med Chem; 2022; 22(4):605-628. PubMed ID: 33305713
[TBL] [Abstract][Full Text] [Related]
72. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
Lau HCH; Sung JJ; Yu J
Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
[TBL] [Abstract][Full Text] [Related]
73. Inflammatory bowel disease: The role of commensal microbiome in immune regulation.
Wah-Suárez MI; Vázquez MAM; Bosques-Padilla FJ
Gastroenterol Hepatol; 2022 Oct; 45(8):626-636. PubMed ID: 34543718
[TBL] [Abstract][Full Text] [Related]
74. Gut Microbiome and Its Influence On Ocular Surface and Ocular Surface Diseases.
Thakur S; Sheppard JD
Eye Contact Lens; 2022 Jul; 48(7):278-282. PubMed ID: 35580364
[TBL] [Abstract][Full Text] [Related]
75. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
76. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
[TBL] [Abstract][Full Text] [Related]
77. A Potential Role for Gut Microbes in Mediating Effects of Omega-3 Fatty Acids in Inflammatory Bowel Diseases: A Comprehensive Review.
Arjomand Fard N; Bording-Jorgensen M; Wine E
Curr Microbiol; 2023 Oct; 80(11):363. PubMed ID: 37807005
[TBL] [Abstract][Full Text] [Related]
78. Probiotics, prebiotics and amelioration of diseases.
Tsai YL; Lin TL; Chang CJ; Wu TR; Lai WF; Lu CC; Lai HC
J Biomed Sci; 2019 Jan; 26(1):3. PubMed ID: 30609922
[TBL] [Abstract][Full Text] [Related]
79. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
Zhou Z; Sun B; Yu D; Zhu C
Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
[TBL] [Abstract][Full Text] [Related]
80. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy.
Gori S; Inno A; Belluomini L; Bocus P; Bisoffi Z; Russo A; Arcaro G
Crit Rev Oncol Hematol; 2019 Nov; 143():139-147. PubMed ID: 31634731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
